More Information About NANO SOMA

NANO SOMA^™ has been confirmed to inhibit SARS-COV-2

NANO SOMA^™ inhibits SARS-COV-2

NANO SOMA^™ has been shown to inhibit SARS-COV-2 viral entry by blocking TMPRSS2 and ACE2 receptor in vitro and has been demonstrated to protect SARS-COV-2 positive patients in 3 to 5 days.

Metadichol® (NANO SOMA), a nano lipid formulation of long chain alcohols, has been shown in vitro studies to protect against SARS-COV-2 and it does so by blocking the cell entry points for SARS-COV-2. The receptor ACE2 is used by the virus for entry and the serine protease TMPRSS2 for S protein priming. It inhibits both ACE2 and TMPRSS2. An assay against the virus using CACO2 cells showed that it had an EC90 of 0.16 µg/ml, which means it effectively eliminates the virus at a very low concentration.

Metadichol® inhibits TMPRSS2 (EC50 of 96 ng/ml). It is 270 times more potent than another well-known inhibitor Camostat mesylate, which has EC50 of (26000 ng/ml). Metadichol is also a moderate inhibitor of ACE2 with an EC50 of 31 µg/ml. Moderate inhibition of ACE2 allows it to perform its key functions in the body, yet fend off SARS-COV-2 entry to the cell. ACE2 lowers blood pressure, regulates intestinal neutral amino acid transport. ACE2 expression and function is increasingly recognized as a potential therapeutic strategy in hypertension and cardiovascular disease, diabetes, lung injury, and fibrotic disorders.

Metadichol, by binding to the Vitamin D receptor (VDR), acts on proteases like Furin and Adam-17, which activate the S-protein spikes for viral spread and pathogenesis in the infected hosts. In Malaria, CD147, also known as Basigin, is used by parasites to gain entry into the cell. Recent publications suggest that it also can be used as a point of entry by the SARS-COV-2 virus. Our previous work (US patent 9,006,292) showed that Metadichol is also potent against Malarial parasites and, by association, CD147. All these results and others are documented in our recent publication available at (https://www.researchsquare.com/article/rs-34021/v5)

A pilot study (outside the USA) on five SARS-COV-2 patients with minor indications showed the absence of a virus after 2-4 days of Metadichol @ 20 mg per day. To validate this further, we have initiated a study in collaboration with government agencies. The initial study of 30 patients showed 75% of the patients cleared of the SARS-COV-2 virus after 4 days of treatment – see http://nanorxeurope.com/Documents/India-hospital-letter.pdf

Can NANO SOMA^™ protect me against SARS-COV-2?

As with perhaps all such infections, those most at risk from SARS-COV-2 are those with weakened immune systems. NANO SOMA^™ substitutes for Vitamin D and also triggers the body to produce its own Vitamin C, an ability we lost 40M years ago. Both Vitamin C and Vitamin D play a key role in immunity. So, in these and other ways, NANO SOMA^™ acts to strengthen your immune system, helping to protect you from all types of infection, including SARS-COV-2.

NANO SOMA^™ regulates many of the Nuclear Receptors in our cells

NANO SOMA^™ substitutes for Vitamin D in activating (turning on) the Vitamin D Receptor or VDR. Technically speaking, this means NANO SOMA^™ acts as an agonist for the VDR. However, if the VDR is overactive, such as may occur in an autoimmune disease or some other conditions, it acts to turn off or deactivate the VDR. This makes NANO SOMA^™ also an inverse agonist. According to Raghu, the NANO SOMA^™ developer, there is no other known inverse agonist in the medical literature. Even more, this same particle works in both directions, which means it is intelligent, acting to regulate the VDR for optimum function. It is what is known as a protean agonist or adaptogen. Nothing else does this.

But there’s more… According to Raghu, the VDR is one of 49 nuclear receptors in each cell. These play a key role in development, gene expression and immunity. Raghu understands from his analysis that NANO SOMA^™ interacts with all 49 nuclear receptors. There are only tests available for 27 of these. NANO SOMA^™ has been shown to regulate 22 of these, the other 5 being unclear. This action with the remaining 22 is currently unable to be confirmed.

Can you begin to grasp why NANO SOMA^™ plays such a powerful role in health and helping the body to deal with such an array of illness and disease?

Active Motility of Red Blood Cells due to Metadichol (NANO SOMA)

Dark-field Microscope blood imaging observing the effect of Metadichol (NANO SOMA)

As presented by Dr. Raghavan at 2nd INTERNATIONAL CONFERENCE on PharmScience Research & Development FEBRUARY 24-26, 2020, LOS ANGELES, CA

Pre-Metadichol

A clear clumping of the red blood cells can be seen with numerous small dots which indicate the presence of the Epstein Barr virus. There was no motility of the red blood cells observed as they appeared to be bound together in large groups.

Learn More

Post-Metadichol

After 23 minutes another drop of blood was drawn and the image not only shows a dramatic absence of the white dots as well as a separation of all the red blood cells. Just as astonishingly his red blood cells appeared to show rapid motility on the screen wherever we looked.